
PMC:7156291 / 12172-12419
Annnotations
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T67","span":{"begin":106,"end":109},"obj":"http://purl.obolibrary.org/obo/CLO_0053001"},{"id":"T68","span":{"begin":182,"end":184},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"}],"text":"The time intervals after disease onset (days) were divided into 5 groups, i.e., days 0–3 (lesion number = 114), days 4–7 (lesion number = 241), days 8–10 (lesion number = 189), days 11–14 (lesion number = 178), and days 15–21 (lesion number = 95)."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T130","span":{"begin":0,"end":247},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The time intervals after disease onset (days) were divided into 5 groups, i.e., days 0–3 (lesion number = 114), days 4–7 (lesion number = 241), days 8–10 (lesion number = 189), days 11–14 (lesion number = 178), and days 15–21 (lesion number = 95)."}